Highlights from this issue
Inferring the quality of hospital treatment for COPD by mortality; caution is needed
Pulmonary rehabilitation; what's in a name?
The GOLD Rush
Electronic cigarettes
Effects of high altitude and cold air exposure on airway inflammation in patients with asthma
GOLD classifications and mortality in chronic obstructive pulmonary disease
Donor smoking reduces recipient survival after lung transplant
The effectiveness of a structured education pulmonary rehabilitation programme for improving the health status of people with moderate and severe chronic obstructive pulmonary disease in primary care
Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis
Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis
Morbidity and mortality in children with obstructive sleep apnoea
Surgery for early stage small cell lung cancer
Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy
Daily physical activity in subjects with newly diagnosed COPD
Correspondence on the paper by Krauss–Etschmann S, Bush A, Bellusci S, et al.
The use of benzodiazepines could be a protective factor for community-acquired pneumonia (CAP) in ≤60-year-old subjects
Authors’ response to Almirall et al
Should we give long-term macrolide therapy for COPD?
Response to
Use of mortality within 30 days of a COPD hospitalisation as a measure of COPD care in UK hospitals
Research in progress
Ion channels
Pulmonary arterial enlargement and acute exacerbations of COPD
Antoine-Laurent de Lavoisier (1743–1794) and the birth of respiratory physiology
Clinical presentation
Post-traumatic pulmonary hernia
What's hot that the other lot got